Unknown PHASE4 INTERVENTIONAL 2-arm NCT02156050

Use of a New Phototherapy Device (BBloo®) for the Treatment of Hyperbilirubinemia in the Newborn Infant (ICT-O2)

Utilisation du Dispositif BBloo® Pour le Traitement de l'ictère néonatal : Satisfaction Des Parents et Des Personnels Soignants

Sponsor: Association Pédiatrique des Groupes d'Acuueil et de Recherche

Conditions Neonatal Hyperbilirubinemia

Interventions two sessions of 4 hours Phototherapy treatment

Updated 5 times since 2017 Last updated: Jun 3, 2014 Started: Dec 31, 2013 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Neonatal Hyperbilirubinemia, this trial is ongoing. The trial is conducted by Association Pédiatrique des Groupes d'Acuueil et de Recherche and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Association Pédiatrique des Groupes d'Acuueil et de Recherche
Bicetre Hospital
Hopital Antoine Beclere

Data source: Association Pédiatrique des Groupes d'Acuueil et de Recherche

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Clamart, France
• Le Kremlin-Bicêtre, France